中文

← All funding rounds

Atomic AI

United StatesDrug discoverySan Francisco, United StatesPrivate

Website · atomic.ai ↗

Predicts 3D RNA structure with machine learning (ATOM-1) plus in-house wet-lab assays, to design small molecules that hit RNA and RNA-based medicines.

Disclosed total$42M
Rounds on record2
Latest round$35MSeries A · 2023-01-25
Last stated valuationNone stated
Investors named14
Research on record1highest level 2 · Computed

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date2023202420252026$35M$7MEvidencelevel of each research entry12345
Closed roundResearch entry, at its level

Latest round, Series A, 2023-01-25: the record then held no research entry for the company. The first research entry is dated 2023-12-14; the highest level so far is 2 (Computed).

Rounds and research, on one timeline

  1. 2023-12-14
    Research

    Level 2 · Computed

    Atomic AI's ATOM-1 preprint: an RNA model trained on chemical-mapping data it measured itself

    A startup measuring its own training data is the model's real edge. The abstract names no benchmark, so how far ahead it is stays unchecked, and nothing here is a designed RNA tested in a lab.

    Timeline entry →biorxiv.org ↗

  2. 2023-01-25Series A
    Round

    $35M

    For: grow the AI and RNA structure platform

    Models and platform

    Total raised $42M with the seed.

    Lead · Playground Global ✓8VCFactory HQGreylock ✓NotBoringAME Cloud VenturesNat FriedmanDoug MohrNeal KhoslaPatrick Hsu

    On the deal: Doug Mohr (Angel investor); Jory Bell (General Partner, Playground Global); Nat Friedman (Angel investor); Neal Khosla (Angel investor); Patrick Hsu (Angel investor); Saam Motamedi (Partner, Greylock)

    Announced by the company · biospace.com ↗

  3. 2023-01-25date disclosed · close date not givenSeed
    Round

    $7M

    Not stated

    First disclosed in the Series A announcement; its date was not given.

    Lead · 8VCGreylock ✓Factory HQAME Cloud VenturesAIX Ventures ✓Xu VenturesDoug MohrChristina SmolkeDrew Endy

    On the deal: Christina Smolke (Angel investor); Drew Endy (Angel investor)

    Announced by the company · biospace.com ↗

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

On the investors' own sites

Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.

Its investors also backed

Other companies on this page whose rounds name the same investor.